Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans.
For oral use in dogs only.
As with any NSAID all dogs should undergo a thorough history and physical examination before the initiation of NSAID therapy. Appropriate laboratory testing to establish hematological and serum biochemical baseline data is recommended prior to and periodically during administration. Owner should be advised to observe their dog for signs of potential drug toxicity and be given a client information sheet about OstiLox.
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
OstiLox Oral Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs.
There is currently no drug history available for this drug.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class. Each milliliter of OstiLox™ Oral Suspension contains meloxicam equivalent to 1.5 milligrams and sodium benzoate (1.5 milligrams) as a preservative. The chemical name for Meloxicam is 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carbox-amide-1, 1-dioxide. The formulation is a yellowish viscous suspension.